New York Genome Center

The New York Genome Center (NYGC) is a recently launched collaborative effort between 12 leading academic medical centers and research universities in the New York metropolitan area, including Northwell Health.  NYGC’s mission is to transform biomedical research and clinical care in New York and beyond through the creation of what will become one of the largest bioinformatics and genomics facilities in North America.

The first major project being undertaken by this new collaborative is led by Peter Davies, PhD, head of the Litwin Zucker Center for Research in Alzheimer’s Disease and Memory Disorders at the Feinstein Institute.  In this project, the full genomes of 1,000 Alzheimer’s patients, and 400 healthy controls, will be sequenced, and the full data set will be made freely available to the scientific community.